New vaccine!

This year we have a new vaccine, against meningococcus B. It was a vaccine long awaited by all of us and now I will explain why:

1. Meningococcus B is the leading cause of bacterial (severe) meningitis in our environment. The leading global cause of meningitis is viruses, which cause benign (mild) symptoms.

2. Meningococcal B meningitis, although not very common (less than one case per 100,000 inhabitants), has a high lethality: out of 10 meningococcal patients, 1 will die.

3. The approved and marketed vaccine is called Bexsero, and is not funded by the public health system.

4. The pattern of administration is different depending on the age of the child: between 4 doses in children under 6 months, 3 to 2 years and 2 in adults.

5. It is a very safe vaccine but often causes mild side effects within the next 24 hours of administration: redness and pain in the area of ??the sting and fever. It is recommended to take paracetamol prophylactically.